Painkiller diclofenac linked to increased heart risks in study
Diclofenac, a commonly used painkiller, was associated with an increased risk of major cardiovascular problems compared with no medication or other medication. (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 5, 2018 Category: Consumer Health News Source Type: news
Common painkiller prescribed to MILLIONS increases risk of a stroke
Heart concerns caused British regulators to ban tablet forms of the drug diclofenac from being sold over-the-counter in 2015. It can still be bought from pharmacies in its gel form, such as Voltaren. (Source: the Mail online | Health)
Source: the Mail online | Health - September 5, 2018 Category: Consumer Health News Source Type: news
Call to curb use of common painkiller due to cardiovascular risk
The commonly used painkiller diclofenac is associated with an increased risk of major cardiovascular events, according to a study in Denmark. (Source: Nursing Times)
Source: Nursing Times - September 5, 2018 Category: Nursing Source Type: news
MyNicNaxs, LLC Issues Voluntary Nationwide Recall of Various Dietary Supplements Due to Undeclared Active Pharmaceutical Ingredient (API)
MyNicNaxs, LLC, Deltona, FL is voluntarily recalling all lots of dietary supplements distributed nationwide to the consumer level. The products have been found to contain undeclared active pharmaceutical ingredients (API). The presence of Sildenafil, Sibutramine, Diclofenac and/or Phenolphthalein in the dietary supplements renders it an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall. These products were distributed from January 2013, to December 2017, though our website http://www.mynicnaxs.com. The undeclared drug ingredients found in these products may pose serio...
Source: Food and Drug Administration - July 11, 2018 Category: Food Science Source Type: news
Diclofenac May Boost MI Risk in Patients With Spondyloarthritis Diclofenac May Boost MI Risk in Patients With Spondyloarthritis
Risk of myocardial infarction (MI) is increased in patients with spondyloarthritis (SpA) who use the nonsteroidal anti-inflammatory drug (NSAID) diclofenac but not in those who take naproxen, researchers say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 7, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news
Diclofenac Raises MI Risk in Spondyloarthritis (CME/CE)
(MedPage Today) -- No special risk seen for naproxen (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 25, 2018 Category: Cardiology Source Type: news
Ingenol Mebutate vs. Diclofenac Sodium for Actinic Keratosis Ingenol Mebutate vs. Diclofenac Sodium for Actinic Keratosis
This study compared the efficacy and outcomes of two approved treatments for actinic keratosis on the face and scalp: ingenol mebutate and diclofenac sodium. Is one superior to the other?The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 10, 2018 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news
Diclofenac Sodium Extended Release Tablets (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 4, 2018 Category: Drugs & Pharmacology Source Type: news
Diclofenac Patch, Piroxicam Most Effective Topical NSAIDs for Osteoarthritis Diclofenac Patch, Piroxicam Most Effective Topical NSAIDs for Osteoarthritis
Diclofenac patches appear to be the most effective topical nonsteroidal anti-inflammatory drug (NSAID) for osteoarthritis (OA), according to a new systematic review and network meta-analysis.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 1, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news
FDA Drug Safety Communication: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes
[FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes (FDA Drug Safety Communication). Based on FDA ’s comprehensive review of new safety information, the agency is requiring updates to the drug labels of all prescription NSAIDs. Widely used to treat pain and fever from many different long- and short-term medical conditions such as arthritis, menstrual cramps, headaches, colds, and the flu, NSAI Ds are available by prescription and OTC. Examples of NSAIDs include ibuprofen, naproxen, diclofenac, and celecoxib. (Source: FDA Center for Drug Evaluation and...
Source: FDA Center for Drug Evaluation and Research - What's New - November 16, 2017 Category: Drugs & Pharmacology Source Type: news
Symptomatic treatment of uncomplicated lower urinary tract infections in the ambulatory setting: randomised, double blind trial
This research article concludes that diclofenac is inferior to norfloxacin for symptom relief of Urinary Tract Infections at day three. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 10, 2017 Category: Consumer Health News Source Type: news
Nuvo Pharmaceuticals(TM) Inc. Announces Topline Results from European Ankle Sprain Study with Pennsaid(R) 2%
Pennsaid 2% Already Approved for Marketing in the United States and Russia
MISSISSAUGA, ON, May 15, 2017 -- (Healthcare Sales & Marketing Network) - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI), a commercial healthcare company with a portf... Biopharmaceuticals Nuvo Pharmaceuticals, Pennsaid, diclofenac, ankle, sprain (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 15, 2017 Category: Pharmaceuticals Source Type: news
Ibuprofen linked to increased risk of heart attacks
Conclusion
This study is a useful addition to our knowledge about the links between NSAIDs and heart attack risk. The study suggests all commonly-used NSAIDs are linked to a similarly-raised risk of heart attacks, that the risk generally rises with the dose, and that it is highest in the first month of treatment.
The researchers did a good job at taking account of potential confounding factors that could have affected the results. Even so, we don't know for sure that the NSAIDs were the direct cause of the problem. For example, if you are prescribed NSAIDs for a painful condition, and have a heart attack two weeks later, i...
Source: NHS News Feed - May 10, 2017 Category: Consumer Health News Tags: Heart/lungs Medication Source Type: news
Class 2 medicines recall (action within 48 hours): Diclo-SR 75 Tablets (Diclofenac Sodium)
The Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a class 2 medicines recall (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 29, 2017 Category: Drugs & Pharmacology Source Type: news
